Genmab Announces Preclinical Data to be Presented at American Association for Cancer Research (AACR) Annual Meeting 2021

NEXT STORY
Turning Point Therapeutics to Present New Preclinical Data For Three Drug Candidates at American Association For Cancer Research Annual Meeting
PREV STORY
Affimed Announces Presentations at the AACR Annual Meeting 2021
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Turning Point Therapeutics Announces Commencement of Public Offering of Common Stock

author_avatar
NASDAQ Market News

Publishing of Orion Corporation’s Interim Report for January-March 2017 on 26 April 2017

ORION CORPORATION         STOCK EXCHANGE RELEASE 12 APRIL 2017 at 12.00 noon EEST                       Publishing ...

author_avatar
NASDAQ Market News

Roche to present first clinical data on novel anti-TIGIT cancer immunotherapy tiragolumab at ASCO

author_avatar
NASDAQ Market News